Skip to main content
. Author manuscript; available in PMC: 2010 Nov 24.
Published in final edited form as: J Am Coll Cardiol. 2009 Nov 24;54(22):2052–2062. doi: 10.1016/j.jacc.2009.08.028

Table 4. Table 4A. Cox Regression with Multiple Predictor Variables Including Location and Type of Mutations and their Interaction for First Cardiac Event.

Hazard Ratio 95% Confidence Interval P Value
1. Mutation Location by Type
Transmembrane pore (S5-loop-S6) / C-terminus (reference)
  Missense mutations 2.87 2.03 4.07 <0.001
  Non-missense mutations 1.13 0.65 1.95 0.663
N-terminus / C-terminus (reference)
  Missense mutations 1.86 1.25 2.78 0.002
  Non-missense mutations 0.77 0.50 1.17 0.220
Transmembrane non-pore (S1-S4) / C-terminus (reference)
  Missense mutations 1.19 0.59 2.39 0.632
  Non-missense mutations 0.46 0.18 1.17 0.103
2. Mutation Type by Location
Non-missense / Missense (reference)
  C-terminus location 2.00 1.33 3.00 0.001
  Other locations (N-terminus, S1-S4, S5-loop-S6) n.s.
3. Interaction Between Mutation Location and Type* --- --- --- 0.008

Table 4B. Cox Regression with Multiple Predictor Variables Including Location and Type of Mutations and their Interaction for Aborted Cardiac Arrest / LQT-Death

Hazard Ratio 95% Confidence Interval P Value
1. Mutation Location by Type
Transmembrane pore (S5-loop-S6) / C-terminus (reference)
  Missense mutations 1.65 0.93 2.91 0.085
  Non-missense mutations 0.57 0.19 1.74 0.324
N-terminus / C-terminus (reference)
  Missense mutations 1.95 0.99 3.83 0.052
  Non-missense mutations 0.80 0.37 1.73 0.575
Transmembrane non-pore (S1-S4) / C-terminus (reference)
  Missense mutations 1.94 0.61 6.20 0.264
  Non-missense mutations 0.55 0.12 2.56 0.446
2. Mutation Type by Location
Non-missense / Missense (reference)
  C-terminus location 1.75 0.85 3.61 0.131
  Other locations (N-terminus, S1-S4, S5-loop-S6) n.s.
3. Interaction Between Mutation Location and Type* --- --- --- 0.208

Note: Items 1, 2, and 3 identify risk factors from the same model. The model adjusted for enrolling site, gender X age, QTc, and time-dependent beta-blockers as in Table 3. When family members who experienced LQTS-related SCD without being genotyped were omitted from the analyses, the hazard ratios, confidence intervals, and p-values for location and type of mutation were similar to those values in the above table, but the significance for the interaction between mutation location and type was reduced from p=0.008 to p=0.09.

*

The interaction between mutation location and type measures whether the cardiac event risk for a location relative to the C-terminus varies significantly between missense and non-missense mutations. The hazard ratio and confidence intervals are not provided for this interaction since the p-value is an overall significance level for three interaction terms.

See note in Table 4A. Model adjusted for enrolling site, gender X age, QTc, and time-dependent syncope and beta-blockers as in Table 3.

*

The interaction between mutation location and type measures whether the cardiac event risk for a location relative to the C-terminus varies significantly between missense and non-missense mutations. The hazard ratio and confidence intervals are not provided for this interaction since the p-value is an overall significance level for three interaction terms.